Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: Clinical and economic outcomes

Journal of Thoracic and Cardiovascular Surgery

Volumn 141, Issue 6, 2011, Pages 1469-1477.e2

  Uber, Walter E ^a   Toole, John M ^b   Stroud, Martha R ^b   Haney, Jason S ^a   Lazarchick, John ^b   Crawford Jr , Fred A ^b   Ikonomidis, John S ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; COUMARIN; FRESH FROZEN PLASMA; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; AGED; ARTICLE; CARDIOVASCULAR SURGERY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE CONCENTRATE; FEMALE; HEMOSTASIS; HOSPITAL COST; HUMAN; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; MALE; OPERATION DURATION; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; REFRACTORY BLEEDING; REOPERATION; RISK FACTOR; SURVIVAL RATE; THROMBOCYTE TRANSFUSION; THROMBOSIS;

EID: 79956091197     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2011.02.033     Document Type: Article

References (25)

1. L.J. Dacey, J.J. Munoz, Y.R. Baribeau, E.R. Johnson, S.J. Lahey, and B.J. Leavitt Reexploration for hemorrhage following coronary artery bypass grafting Arch Surg 133 1998 442 447 (Pubitemid 28193531)
2. M.J. Moulton, L.L. Creswell, M.E. Mackey, J.L. Cox, and M. Rosenbloom Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operation J Thorac Cardiovasc Surg 111 1996 1037 1046 (Pubitemid 26146058)
3. M.J. Unsworth-White, A. Herriot, O. Valencia, J. Poloniecki, E.E.J. Smith, and A.J. Murday Resternotomy for bleeding after cardiac operation: A marker for increased morbidity and mortality Ann Thorac Surg 59 1995 664 667
4. C.G. Koch, L. Li, A.I. Duncan, T. Mihaljevic, D.M. Cosgrove, and F.D. Lamp Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting Crit Care Med 34 2006 1608 1616 (Pubitemid 43810038)
5. K. Karkouti, D.N. Wijeysundera, T.M. Yau, W.S. Beattie, E. Abdelnaem, and S.A. McCluskey The independent association of massive blood loss with mortality in cardiac surgery Transfusion 44 2004 1453 1462 (Pubitemid 39318980)
6. G.J. Murphy, B.C. Reeves, C.A. Rogers, S.I.A. Rizvi, L. Culliford, and G.D. Angelini Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery Circulation 116 2007 2544 2552 (Pubitemid 350179219)
7. M.C. Christensen, S. Krapf, A. Kempel, and C. von Heymann Costs of excessive postoperative hemorrhage in cardiac surgery J Thorac Cardiovasc Surg 138 2009 687 693
8. S. Al-Ruzzeh, K. Ibrahim, and J.L. Navia Con: the role of recombinant factor VIIa in the control of bleeding after cardiac surgery J Cardiothorac Vasc Anesth 22 2008 783 785
9. S. Romagnoli, S. Bevilacqua, S. Gelsomino, S. Pradella, L. Ghilli, and C. Rostagno Small-dose recombinant activated Factor VII (NovoSeven) in cardiac surgery Anesth Analg 102 2006 1320 1326
10. P. Raivio, R. Suojaranta-Ylinen, and A.H. Kuitunen Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery Ann Thorac Surg 80 2005 66 71 (Pubitemid 40840184)
11. K. Karkouti, T.M. Yau, S. Riazi, K.M. Dattilo, M. Wasowicz, and M. Meineri Determinants of complications with recombinant factor VIIa for refractory blood loss in cardiac surgery Can J Anesth 53 2006 802 809 (Pubitemid 44420066)
12. K. Karkouti, W.S. Beattie, D.N. Wijeysundera, T.M. Yau, S.A. McCluskey, and M. Ghannam Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis Transfusion 45 2005 26 34
13. A.D. Clark, W.C. Gordon, I.D. Walker, and R.C. Tait "Last- ditch" use of recombinant factor VIIa in patients with massive haemorrhage is ineffective Vox Sang 86 2004 120 124 (Pubitemid 38436890)
14. L. Tritapepe, V. De Santis, D. Vitale, C. Nencini, F. Pellegrini, and G. Landoni Recombinant activated factor VII for refractory bleeding after acute aortic dissection: a propensity score analysis Crit Care Med 35 2007 1685 1690 (Pubitemid 46985870)
15. L.J. Bowman, W.E. Uber, M.R. Stroud, L.R. Christiansen, J. Lazarchick, and A.J. Crumbley III Use of recombinant activate factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery Ann Thorac Surg 85 2008 1669 1677 (Pubitemid 351608196)
16. S. Gelsomino, R. Lorusso, S. Romagnoli, S. Bevilacqua, G. De Cicco, and G. Bille Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis Eur J Cardiothorac Surg 33 2008 64 71 (Pubitemid 350266356)
17. K. Karkouti, W.S. Beattie, R. Arellano, T. Aye, J.S. Bussieres, and J.L. Callum Comprehensive Canadian review of the off-label use of recombinant activate factor VII in cardiac surgery Circulation 118 2008 331 338
18. F. Masud, F. Bostan, E. Chi, S.E. Pass, H. Samir, and K. Stuebing Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes J Cardiothorac Vasc Anesth 23 2009 28 33
19. R. Gill, M. Herbertson, A. Vuylsteke, P. Skov Olsen, C. von Heymann, and M. Mythen Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery Circulation 120 2009 21 27
20. K. Karkouti, and W.S. Beattie Pro: the role of recombinant factor VIIa in cardiac surgery J Cardiothorac Vasc Anesth 22 2008 779 782
21. M. Wasowicz, M. Meineri, S.M. McCluskey, N. Mitsakakis, and K. Karkouti The utility of thromboelastography for guiding recombinant activate factor VII therapy for refractory hemorrhage after cardiac surgery J Cardiothorac Vasc Anesth 23 2009 828 834
22. A. Zangrillo, A. Mizzi, G. Biondi-Zoccai, E. Bignami, M. Grazia Calabro, and F. Pappalardo Recombinant activated factor VII in cardiac surgery: a meta-analysis J Cardiothorac Vasc Anesth 23 2009 34 40
23. K. Karkouti, W.S. Beattie, M.A. Crowther, J.L. Callum, R. Chun, and S.E. Fremes The role of recombinant factor VIIa in on-pump cardiac surgery: proceeding of the Canadian consensus conference Can J Anesth 54 2007 573 582 (Pubitemid 47090893)
24. J.F. Hardy, S. Belisle, and P. Van der Linden Efficacy and safety of activated recombinant factor VII in cardiac surgical patients Curr Opin Anaesthesiol 22 2009 95 99
25. K.A. O'Connell, J.J. Wood, R.P. Wise, J.N. Lozier, and M.M. Braun Thromboembolic adverse events after the use of recombinant human coagulation factor VIIa JAMA 295 2006 293 298 (Pubitemid 43112957)